A1c Test
About A1c
Glycated Hemoglobin (also known as HbA1c or A1c) is our most advanced and ground-breaking electrochemical product technology. Our work on this important test has yielded a patented design that performs as well as existing laboratory tests but does so with a single drop of blood and provides results in seconds. Patents are finalized and filed. We are pursuing opportunities to market this product within the diagnostics industry.
A1c Market Discussion
- World Health Organization estimates 347 million will have diabetes by 2030, with 298 million of those in developing countries
- Offer an opportunity to replace existing methods testing in developed countries in the Americas, Europe, & Japan
- Offer an enormous opportunity in the emerging markets of China, India, & the African continent
- A1c testing was approved by the FDA in early 2018 for use in Dentist’s offices, further expanding target market
A1c Performance vs. Reference
Exclusive IVD Patents
Glycated Hemoglobin (also known as HbA1c or A1c) is our most advanced and ground-breaking electrochemical product technology. Our work on this important test has yielded a patented design that performs as well as existing laboratory tests but does so with a single drop of blood and provides results in seconds. Patents are finalized and filed.